Australian data do not support current Pharmaceutical Benefits Scheme criteria for use of tumour necrosis factor-alpha inhibitors in ankylosing spondylitis
Contribuinte(s) |
J. Szer J. McCormack Z. Endre et al. |
---|---|
Data(s) |
01/01/2006
|
Identificador | |
Idioma(s) |
eng |
Publicador |
Blackwell Publishing Asia |
Palavras-Chave | #Medicine, General & Internal #CX #320204 Immunogenetics #730114 Skeletal system and disorders (incl. arthritis) |
Tipo |
Journal Article |